[18F]fluorocholine PET vs. [99mTc]sestamibi scintigraphy for detecting parathyroid glands
Author Information
Author(s): Sebastijan Rep, Klara Sirca, Ema Macek Lezaic, Katja Zaletel, Marko Hocevar, Luka Lezaic
Primary Institution: Division of Nuclear Medicine, University Medical Centre Ljubljana, Slovenia
Hypothesis
The study aims to determine the resource efficiency and patient outcomes of FCh-PET/CT in comparison to conventional MIBI scintigraphy.
Conclusion
FCh-PET/CT reduces the time of imaging, the time of surgery, and potentially reduces the number of reoperations for persistent disease.
Supporting Evidence
- The time needed to perform imaging was reduced by 83% after FCh-PET/CT compared to MIBI scintigraphy.
- Persistent hypercalcemia was more often observed in patients who underwent MIBI SS and SPECT/CT (15.8%) compared to those who underwent FCh-PET/CT (2.4%).
- Reoperation was required in 12.3% of patients who underwent SS and SPECT/CT, compared to 1.8% of patients who had FCh-PET/CT.
Takeaway
Using a special scan called FCh-PET/CT helps doctors find problem areas in the neck faster and makes surgery quicker, which can help patients get better sooner.
Methodology
A retrospective analysis comparing outcomes and resource efficiency between 234 patients who underwent surgery after MIBI scintigraphy and 163 patients who underwent surgery after FCh-PET/CT.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Patients with primary hyperparathyroidism who underwent surgery.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website